From existing antivirals to new antibody therapies – researchers are working tirelessly to find the best drugs to treat Covid-19.
This web page was last updated in 2021. The information provided here may not reflect current developments or research.
Covid-19 treatments explained
For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic.
How we're supporting research
We launched the COVID-19 Therapeutics Accelerator together with the Bill & Melinda Gates Foundation and Mastercard.
This is a large-scale collaboration to research, develop and bring effective treatments to market quickly and accessibly. The studies funded so far include evaluating approved drugs and creating platforms for exploring new potential treatments.
Treatments for everyone
All effective treatments against Covid-19 – wherever they’re developed – must be distributed equitably around the world, starting with the places that need them most urgently. If not, the virus can never be brought under control.
Governments and international organisations can help to get lifesaving Covid-19 tests, treatments and vaccines from the laboratory to the front line by investing in the ACT-Accelerator.
Coronavirus treatments and vaccines should first be made available to those who need them most, public polling in several countries shows.